What is the current Cochlear market capitalization?
The current market capitalization of Cochlear is 18.94 B AUD.
Cochlear Market capitalization 2024
Cochlear Market capitalization
18.94 B AUD
Ticker
COH.AX
ISIN
AU000000COH5
WKN
898321
In 2024, Cochlear's market cap stood at 18.94 B AUD, a 11.2% increase from the 17.03 B AUD market cap in the previous year.
The Cochlear Market capitalization history
| YEAR | Market Capitalization (undefined AUD) |
|---|---|
| 2024 | 18.94 |
| 2023 | 16.07 |
| 2022 | 13.78 |
| 2021 | 14.59 |
| 2020 | 12.16 |
| 2019 | 11.69 |
| 2018 | 10.81 |
| 2017 | 8.68 |
| 2016 | 6.76 |
| 2015 | 4.95 |
| 2014 | 3.66 |
| 2013 | 3.63 |
| 2012 | 3.74 |
| 2011 | 3.98 |
| 2010 | 4.05 |
| 2009 | 3.21 |
| 2008 | 3.07 |
| 2007 | 3.61 |
| 2006 | 2.88 |
| 2005 | 1.94 |
Cochlear Aktienanalyse
What does Cochlear do?
Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Cochlear's Market Capitalization
Cochlear's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Cochlear's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Cochlear's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Cochlear’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Cochlear stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Cochlear.
How has the market capitalization of Cochlear developed in recent years?
The market capitalization of Cochlear has increased/decreased by 11.2% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Cochlear?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Cochlear?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Cochlear have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Cochlear pay?
Over the past 12 months, Cochlear paid a dividend of 5.42 AUD . This corresponds to a dividend yield of about 1.88 %. For the coming 12 months, Cochlear is expected to pay a dividend of 5.68 AUD.
What is the dividend yield of Cochlear?
The current dividend yield of Cochlear is 1.88 %.
When does Cochlear pay dividends?
Cochlear pays a quarterly dividend. This is distributed in the months of April, October, April, October.
How secure is the dividend of Cochlear?
Cochlear paid dividends every year for the past 26 years.
What is the dividend of Cochlear?
For the upcoming 12 months, dividends amounting to 5.68 AUD are expected. This corresponds to a dividend yield of 1.97 %.
In which sector is Cochlear located?
Cochlear is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cochlear kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cochlear from 10/10/2024 amounting to 2.82 AUD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.
When did Cochlear pay the last dividend?
The last dividend was paid out on 10/10/2024.
What was the dividend of Cochlear in the year 2023?
In the year 2023, Cochlear distributed 4.058 AUD as dividends.
In which currency does Cochlear pay out the dividend?
The dividends of Cochlear are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cochlear
Our stock analysis for Cochlear Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cochlear Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
